XML 62 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated statements of income - EUR (€)
€ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenue:      
Health care services € 15,393,936 € 15,418,069 € 13,876,282
Health care products 4,059,681 3,979,948 3,742,403
Revenue 19,453,617 19,398,017 17,618,685
Costs of revenue:      
Health care services 12,178,846 12,243,835 10,941,279
Health care products 2,349,766 2,260,493 1,904,377
Costs of revenue 14,528,612 14,504,328 12,845,656
Operating (income) expenses:      
Selling, general and administrative 3,196,336 3,170,370 2,772,831
Research and development 231,970 228,624 220,782
Income from equity method investees (121,785) (66,559) (92,175)
Other operating income (515,247) (549,853) (567,787)
Other operating expense 764,293 747,554 587,088
Remeasurement Gain from InterWell Health   (148,202)  
Operating income 1,369,438 1,511,755 1,852,290
Other (income) expense:      
Interest income (88,217) (67,663) (73,170)
Interest expense 424,640 360,139 353,599
Income before income taxes 1,033,015 1,219,279 1,571,861
Income tax expense 300,557 324,954 352,833
Net income 732,458 894,325 1,219,028
Net income attributable to noncontrolling interests 233,461 220,920 249,720
Net income attributable to shareholders of FME AG € 498,997 € 673,405 € 969,308
Basic earnings per share € 1.70 € 2.30 € 3.31
Diluted earnings per share € 1.70 € 2.30 € 3.31